Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy-Reference-Cited by-同舟云学术

Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy

Published:2019-11-21 Issue:12 Volume:60 Page:2437-2447
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Ben‐Menachem Elinor¹^ORCID,Grebe Hans Peter²,Terada Kiyohito³^ORCID,Jensen Lori⁴,Li Ting⁴,De Backer Marc⁵,Steiniger‐Brach Björn⁵,Gasalla Teresa⁴,Brock Melissa⁴,Biton Victor⁶

Affiliation:

1. Institute for Clinical Neuroscience and Physiology Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

2. Department of Neurology Hospital São Sebastião Centro Hospitalar de Entre o Douro e Vouga Santa Maria da Feira Portugal

3. NHO Shizuoka Institute of Epilepsy and Neurological Disorders Shizuoka Japan

4. UCB Pharma Raleigh NC USA

5. UCB Pharma Brussels Belgium

6. Arkansas Epilepsy Program Clinical Trials Inc Little Rock AR USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.16381

Reference23 articles.

1. Antiepileptic Drug Monotherapy: The Initial Approach in Epilepsy Management

2. Vimpat® (lacosamide) Summary of Product Characteristics.Brussels Belgium:UCB Pharma SA;2018. Available at:https://www.ema.europa.eu/documents/product-information/vimpat-epar-product-information_en.pdf. Accessed June 10 2019.

3. Vimpat® (lacosamide) C‐V Prescribing Information.Smyrna GA:UCB Inc;2019. Available at:https://www.vimpat.com/vimpat-prescribing-information.pdf. Accessed June 10 2019.

4. Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial-Onset Seizures

5. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching carbamazepine to lacosamide improves gamma‐glutamyl transpeptidase levels;Epilepsia Open;2024-08-14

2. Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real‐world study;CNS Neuroscience & Therapeutics;2024-08

3. Clinical observation and analysis of rash caused by lacosamide in children with epilepsy;Seizure: European Journal of Epilepsy;2024-04

4. Risk assessment of arrhythmias related to three antiseizure medications: a systematic review and single-arm meta-analysis;Frontiers in Neurology;2024-02-14

5. Research Status, Synthesis and Clinical Application of Antiepileptic Drugs;Current Medicinal Chemistry;2024-02